Search results
Gaps remain between what's known about obesity and how it's being treated
Stamford Advocate· 20 hours agoThe scientific statement from the American Heart Association, published Monday in the journal Circulation, highlights gaps between the growing understanding of the causes and
Is Eli Lilly Stock A Buy Or A Sell With Key Alzheimer's Meeting Looming?
Investor's Business Daily· 6 days agoEli Lilly stock yo-yoed recently after announcing the Food and Drug Administration has scheduled an...
Eli Lilly’s diabetes drug tirzepatide gets approval in China
KFGO· 1 hour agoSHANGHAI (Reuters) - Eli Lilly said on Tuesday its diabetes drug tirzepatide has received approval...
Eli Lilly's diabetes drug tirzepatide gets approval in China
Reuters via AOL· 8 hours agodrug tirzepatide has received approval from Chinese regulators, setting up intensifying competition...
Expert shares what to expect after hip replacement surgery
UPI· 1 hour agoOlder hip implants were made of metal, but newer ones are largely composed of ceramic and plastic,...
Eli Lilly's diabetes drug tirzepatide gets approval in China
Reuters· 8 hours agoNovo Nordisk's popular diabetes drug Ozempic won approval from China in 2021 and the company saw...
Hims & Hers says it's selling a GLP-1 weight loss drug for 85% less than Wegovy. Here's the price.
CBS News· 22 hours agoDirect-to-consumer pharmaceutical startup Hims & Hers Health said it is selling injectable GLP-1...
Medicare Coverage of Wegovy Raises Questions Regarding the Affordability and Accessibility of Novel...
The National Law Review· 6 days agoIn Wegovy’s case, the FDA...cardiovascular death, non-fatal myocardial infarction, or non-fatal...
Roche's experimental obesity drug shows promising early stage results
United Press International via Yahoo News· 5 days agoSwiss drug company Roche on Thursday said its experimental obesity treatment helped people lose a...
A pill could solve the Zepbound and Wegovy shortage, Eli Lilly executive says
Quartz· 6 days agoThe pharma giant is doing all it can to ramp up production of its highly-coveted diabetes and weight...